{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:15:37Z","timestamp":1780618537023,"version":"3.54.1"},"reference-count":164,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The cardinal pathology of coronavirus disease 2019 (COVID-19) is a primary infection of pulmonary tract cells by severe acute respiratory syndrome coronavirus 2, provoking a local inflammatory response, often accompanied by cytokine storm and acute respiratory distress syndrome, especially in patients with severe disease. Systemic propagation of the disease may associate with thrombotic events, including deep vein thrombosis, pulmonary embolism, and thrombotic microangiopathy, which are important causes of morbidity and mortality in patients with COVID-19. This narrative review describes current knowledge of the pathophysiological mechanisms of COVID-19-associated coagulopathy, with focus on prothrombotic changes in hemostatic mediators, including plasma levels of clotting factors, natural anticoagulants, components of fibrinolytic system, and platelets. It will also highlight the central role of endothelial cells in COVID-19-associated coagulopathy. This narrative review discusses also potential therapeutic strategies for managing thrombotic complications. Awareness by medical experts of contributors to the pathogenesis of thrombotic events in COVID-19 is imperative to develop therapeutics not limited to regular anticoagulants. Instituting cooperation among medical personnel and researchers may lessen this novel virus' impact now, and in the event of recurrence.<\/jats:p>","DOI":"10.1055\/s-0041-1736166","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T22:56:59Z","timestamp":1635202619000},"page":"019-030","source":"Crossref","is-referenced-by-count":23,"title":["The Impact of SARS-CoV-2 Infection on Blood Coagulation and Fibrinolytic Pathways: A Review of Prothrombotic Changes Caused by COVID-19"],"prefix":"10.1055","volume":"48","author":[{"given":"Mehran","family":"Bahraini","sequence":"additional","affiliation":[{"name":"Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akbar","family":"Dorgalaleh","sequence":"additional","affiliation":[{"name":"Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2021,10,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijsu.2020.02.034","article-title":"World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19)","volume":"76","author":"C Sohrabi","year":"2020","journal-title":"Int J Surg"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5582\/bst.2020.01020","article-title":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)","volume":"14","author":"H Lu","year":"2020","journal-title":"Biosci Trends"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"101623","DOI":"10.1016\/j.tmaid.2020.101623","article-title":"Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis","volume":"34","author":"A J Rodriguez-Morales","year":"2020","journal-title":"Travel Med Infect Dis"},{"issue":"05","key":"ref5","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.4269\/ajtmh.20-0893","article-title":"Case report: recurrent clinical symptoms of COVID-19 in healthcare professionals: a series of cases from Brazil","volume":"103","author":"C Fernandes Valente Takeda","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"03","key":"ref6","first-page":"E304","article-title":"Determine the most common clinical symptoms in COVID-19 patients: a systematic review and meta-analysis","volume":"61","author":"Y Alimohamadi","year":"2020","journal-title":"J Prev Med Hyg"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"P Zhou","year":"2020","journal-title":"Nature"},{"issue":"02","key":"ref8","doi-asserted-by":"crossref","first-page":"271.e8","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"M Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"06","key":"ref9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41594-019-0233-y","article-title":"Structural basis for human coronavirus attachment to sialic acid receptors","volume":"26","author":"M A Tortorici","year":"2019","journal-title":"Nat Struct Mol Biol"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.3390\/ijms21124549","article-title":"SARS-CoV-2 evolutionary adaptation toward host entry and recognition of receptor O-Acetyl sialylation in virus\u2013host interaction","volume":"21","author":"C-H Kim","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"09","key":"ref11","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/jth.15016","article-title":"Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis","volume":"18","author":"C Nougier","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref12","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.bja.2020.12.010","article-title":"Impaired fibrinolysis in critically ill COVID-19 patients","volume":"126","author":"M Bachler","year":"2021","journal-title":"Br J Anaesth"},{"issue":"03","key":"ref13","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3390\/ijerph18031268","article-title":"Risk management and treatment of coagulation disorders related to COVID-19 infection","volume":"18","author":"C Zanza","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"05","key":"ref14","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1080\/09537104.2021.1881949","article-title":"Rotational thromboelastometry (ROTEM) profiling of COVID-19 patients","volume":"32","author":"M Mitrovic","year":"2021","journal-title":"Platelets"},{"issue":"23","key":"ref15","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation","volume":"135","author":"J M Connors","year":"2020","journal-title":"Blood"},{"issue":"03","key":"ref16","first-page":"22","article-title":"Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein","volume":"6","author":"A Greinacher","year":"2021","journal-title":"Blood"},{"issue":"02","key":"ref17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/jth.15190","article-title":"Thromboinflammation in COVID-19: can \u03b12 -macroglobulin help to control the fire?","volume":"19","author":"R Seitz","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.mayocp.2020.10.031","article-title":"Coronavirus disease 2019\u2013associated coagulopathy","volume":"96","author":"G Lippi","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"C Huang","year":"2020","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"N Chen","year":"2020","journal-title":"Lancet"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China","volume":"323","author":"D Wang","year":"2020","journal-title":"JAMA"},{"issue":"07","key":"ref22","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"C Wu","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"18","key":"ref23","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"W J Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"F Zhou","year":"2020","journal-title":"Lancet"},{"issue":"06","key":"ref25","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/jth.14830","article-title":"Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia","volume":"18","author":"S Cui","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/CIRCULATIONAHA.120.047407","article-title":"Extremely high incidence of lower extremity deep venous thrombosis in 48 patients with severe COVID-19 in Wuhan","volume":"142","author":"B Ren","year":"2020","journal-title":"Circulation"},{"issue":"02","key":"ref27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.120.046702","article-title":"Deep vein thrombosis in hospitalized patients with COVID-19 in Wuhan, China: prevalence, risk factors, and outcome","volume":"142","author":"L Zhang","year":"2020","journal-title":"Circulation"},{"issue":"08","key":"ref28","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1111\/jth.14888","article-title":"Incidence of venous thromboembolism in hospitalized patients with COVID-19","volume":"18","author":"S Middeldorp","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.120.047430","article-title":"Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence","volume":"142","author":"J Poissy","year":"2020","journal-title":"Circulation"},{"issue":"06","key":"ref30","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"J Helms","year":"2020","journal-title":"Intensive Care Med"},{"issue":"04","key":"ref31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M20-2003","article-title":"Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study","volume":"173","author":"D Wichmann","year":"2020","journal-title":"Ann Intern Med"},{"issue":"06","key":"ref32","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/jth.14844","article-title":"Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19","volume":"18","author":"M Dolhnikoff","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1473-3099(20)30434-5","article-title":"Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study","volume":"20","author":"L Carsana","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"02","key":"ref34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/his.14134","article-title":"Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction","volume":"77","author":"T Menter","year":"2020","journal-title":"Histopathology"},{"issue":"02","key":"ref35","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"M Ackermann","year":"2020","journal-title":"N Engl J Med"},{"issue":"01","key":"ref36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12959-021-00265-y","article-title":"High rate of bleeding and arterial thrombosis in COVID-19: Saudi multicenter study","volume":"19","author":"A Al Raizah","year":"2021","journal-title":"Thromb J"},{"issue":"05","key":"ref37","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/crj.13330","article-title":"A review of venous thromboembolism in COVID-19: a clinical perspective","volume":"15","author":"S Ozsu","year":"2021","journal-title":"Clin Respir J"},{"issue":"04","key":"ref38","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jmv.25688","article-title":"The 2019-new coronavirus epidemic: evidence for virus evolution","volume":"92","author":"D Benvenuto","year":"2020","journal-title":"J Med Virol"},{"issue":"07","key":"ref39","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S2213-2600(20)30243-5","article-title":"Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans","volume":"8","author":"S E Fox","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"07","key":"ref40","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/jth.14849","article-title":"Thromboinflammation and the hypercoagulability of COVID-19","volume":"18","author":"J M Connors","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3324\/haematol.2012.069195","article-title":"Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging technique","volume":"98","author":"K van Langevelde","year":"2013","journal-title":"Haematologica"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Z Varga","year":"2020","journal-title":"Lancet"},{"issue":"07","key":"ref43","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"T Guo","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"08","key":"ref44","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1111\/jth.14860","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19: a comment","volume":"18","author":"C D Barrett","year":"2020","journal-title":"J Thromb Haemost"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00134-016-4621-z","article-title":"Should all patients with sepsis receive anticoagulation? Yes","volume":"43","author":"F Meziani","year":"2017","journal-title":"Intensive Care Med"},{"issue":"02","key":"ref46","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1172\/JCI66843","article-title":"Linking endothelial dysfunction with endothelial cell activation","volume":"123","author":"J K Liao","year":"2013","journal-title":"J Clin Invest"},{"issue":"01","key":"ref47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mvr.2008.09.002","article-title":"The coagulation system and pulmonary endothelial function in acute lung injury","volume":"77","author":"J H Finigan","year":"2009","journal-title":"Microvasc Res"},{"issue":"05","key":"ref48","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1159\/000381102","article-title":"Advances in understanding of the pathogenesis of acute respiratory distress syndrome","volume":"89","author":"C Sharp","year":"2015","journal-title":"Respiration"},{"issue":"03","key":"ref49","doi-asserted-by":"crossref","first-page":"855","DOI":"10.4049\/jimmunol.1402513","article-title":"The acute respiratory distress syndrome: from mechanism to translation","volume":"194","author":"S Han","year":"2015","journal-title":"J Immunol"},{"issue":"01","key":"ref50","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-2006-933338","article-title":"Tissue factor in infection and severe inflammation","volume":"32","author":"M Levi","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"09","key":"ref51","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2174\/138920111798281171","article-title":"Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome","volume":"12","author":"S C Sebag","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"issue":"08","key":"ref52","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study","volume":"7","author":"G Goshua","year":"2020","journal-title":"Lancet Haematol"},{"issue":"03","key":"ref53","first-page":"45","article-title":"Circulating markers of angiogenesis and endotheliopathy in COVID-19","volume":"15","author":"M L Meizlish","year":"2020","journal-title":"medRxiv"},{"issue":"04","key":"ref54","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-0041-1727282","article-title":"Increased VWF and decreased ADAMTS-13 in COVID-19: creating a milieu for (micro)thrombosis","volume":"47","author":"E J Favaloro","year":"2021","journal-title":"Semin Thromb Hemost"},{"issue":"05","key":"ref55","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/a-1155-0501","article-title":"The ACE-2 in COVID-19: foe or friend?","volume":"52","author":"R Dalan","year":"2020","journal-title":"Horm Metab Res"},{"issue":"03","key":"ref56","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1172\/JCI117809","article-title":"Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis","volume":"95","author":"D E Vaughan","year":"1995","journal-title":"J Clin Invest"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"II-34","DOI":"10.1002\/j.1932-8737.1997.tb00010.x","article-title":"Endothelial function, fibrinolysis, and angiotensin-converting enzyme inhibition","volume":"20","author":"D E Vaughan","year":"1997","journal-title":"Clin Cardiol"},{"issue":"01","key":"ref58","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1523-1755.2000.00160.x","article-title":"Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo","volume":"58","author":"S Nakamura","year":"2000","journal-title":"Kidney Int"},{"issue":"01","key":"ref59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1470320313498631","article-title":"Angiotensin-(1-9) enhances stasis-induced venous thrombosis in the rat because of the impairment of fibrinolysis","volume":"15","author":"A Mogielnicki","year":"2014","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3389\/fimmu.2020.02014","article-title":"Understanding the pathophysiology of COVID-19: could the contact system be the key?","volume":"11","author":"S Meini","year":"2020","journal-title":"Front Immunol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.3389\/fimmu.2020.02072","article-title":"Treatment of COVID-19 with conestat alfa, a regulator of the complement, contact activation and Kallikrein-Kinin system","volume":"11","author":"P Urwyler","year":"2020","journal-title":"Front Immunol"},{"issue":"04","key":"ref62","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1159\/000509581","article-title":"Mechanisms of stroke in COVID-19","volume":"49","author":"J D Spence","year":"2020","journal-title":"Cerebrovasc Dis"},{"issue":"11","key":"ref63","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1111\/jth.15029","article-title":"Hypoxia\u2013an overlooked trigger for thrombosis in COVID-19 and other critically ill patients","volume":"18","author":"J Thachil","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref64","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1182\/blood-2018-04-841585","article-title":"Hypoxia downregulates protein S expression","volume":"132","author":"V S Pilli","year":"2018","journal-title":"Blood"},{"issue":"04","key":"ref65","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1182\/blood-2018-06-854976","article-title":"Hypoxia and thrombosis","volume":"132","author":"J T Prchal","year":"2018","journal-title":"Blood"},{"issue":"12","key":"ref66","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"G L Wang","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"01","key":"ref67","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/hh1301.092678","article-title":"Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: role of the p22(phox)-containing NADPH oxidase","volume":"89","author":"A G\u00f6rlach","year":"2001","journal-title":"Circ Res"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.thromres.2019.07.013","article-title":"The stimulation of thrombosis by hypoxia","volume":"181","author":"N Gupta","year":"2019","journal-title":"Thromb Res"},{"issue":"04","key":"ref69","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1172\/JCI114540","article-title":"Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties","volume":"85","author":"S Ogawa","year":"1990","journal-title":"J Clin Invest"},{"issue":"04","key":"ref70","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2141.1990.tb07792.x","article-title":"The effect of hypoxia on capillary endothelial cell function: modulation of barrier and coagulant function","volume":"75","author":"S Ogawa","year":"1990","journal-title":"Br J Haematol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-4615-3806-6_32","article-title":"Modulation of endothelial function by hypoxia: perturbation of barrier and anticoagulant function, and induction of a novel factor X activator","volume":"281","author":"S Ogawa","year":"1990","journal-title":"Adv Exp Med Biol"},{"issue":"06","key":"ref72","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4155\/fmc-2016-0012","article-title":"Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases","volume":"8","author":"S Rivara","year":"2016","journal-title":"Future Med Chem"},{"issue":"05","key":"ref73","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1467-789X.2009.00593.x","article-title":"Role of adipose tissue in haemostasis, coagulation and fibrinolysis","volume":"10","author":"D R Faber","year":"2009","journal-title":"Obes Rev"},{"issue":"01","key":"ref74","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/CIRCULATIONAHA.120.047659","article-title":"Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms","volume":"142","author":"N Sattar","year":"2020","journal-title":"Circulation"},{"issue":"09","key":"ref75","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/cvr\/cvx086","article-title":"New insights into the role of adipose tissue in thrombosis","volume":"113","author":"G Vilahur","year":"2017","journal-title":"Cardiovasc Res"},{"issue":"08","key":"ref76","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/jnnp-2020-323586","article-title":"Characteristics of ischaemic stroke associated with COVID-19","volume":"91","author":"R Beyrouti","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"04","key":"ref77","first-page":"34","article-title":"Lupus anticoagulant is frequent in patients with Covid-19: response to reply","volume":"12","author":"I Harzallah","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"20","key":"ref78","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1056\/NEJMc2009787","article-title":"Large-vessel stroke as a presenting feature of Covid-19 in the young","volume":"382","author":"T J Oxley","year":"2020","journal-title":"N Engl J Med"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1728832","volume-title":"COVID-19 and antiphospholipid antibodies: time for a reality check?","author":"E J Favaloro","year":"2021"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1729856","volume-title":"Is lupus anticoagulant a significant feature of COVID-19? A critical appraisal of the literature","author":"E J Favaloro","year":"2021"},{"issue":"08","key":"ref81","first-page":"680","article-title":"COVID-19 quarantine and acute pulmonary embolism","volume":"73","author":"L Vannini","year":"2020","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"04","key":"ref82","doi-asserted-by":"crossref","first-page":"A1614","DOI":"10.1016\/j.chest.2020.08.1453","article-title":"Seated-immobility thromboembolism syndrome complicating coronavirus disease 2019 outbreak quarantine","volume":"158","author":"A Ali","year":"2020","journal-title":"Chest"},{"issue":"07","key":"ref83","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/jth.14850","article-title":"Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis","volume":"18","author":"M Panigada","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"07","key":"ref84","doi-asserted-by":"crossref","first-page":"e01236","DOI":"10.1213\/XAA.0000000000001236","article-title":"Factor VIII and functional protein C activity in critically ill patients with coronavirus disease 2019: a case series","volume":"14","author":"A Tabatabai","year":"2020","journal-title":"A A Pract"},{"issue":"08","key":"ref85","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/diagnostics10080575","article-title":"Preliminary post-mortem COVID-19 evidence of endothelial injury and factor VIII hyperexpression","volume":"10","author":"L Cipolloni","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"01","key":"ref86","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/rth2.12462","article-title":"Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality","volume":"5","author":"F A von Meijenfeldt","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"issue":"02","key":"ref87","doi-asserted-by":"crossref","first-page":"e9154","DOI":"10.1371\/journal.pone.0009154","article-title":"Endothelial cell processing and alternatively spliced transcripts of factor VIII: potential implications for coagulation cascades and pulmonary hypertension","volume":"5","author":"C L Shovlin","year":"2010","journal-title":"PLoS One"},{"issue":"02","key":"ref88","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1182\/blood-2005-11-4571","article-title":"FVIII production by human lung microvascular endothelial cells","volume":"108","author":"M Jacquemin","year":"2006","journal-title":"Blood"},{"issue":"05","key":"ref89","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1111\/ijlh.13244","article-title":"Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2","volume":"42","author":"A Huisman","year":"2020","journal-title":"Int J Lab Hematol"},{"issue":"03","key":"ref90","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/bloodadvances.2020003968","article-title":"Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge","volume":"5","author":"F A von Meijenfeldt","year":"2021","journal-title":"Blood Adv"},{"issue":"03","key":"ref91","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s11239-020-02182-9","article-title":"Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients","volume":"50","author":"Y Zhang","year":"2020","journal-title":"J Thromb Thrombolysis"},{"issue":"12","key":"ref92","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/ajh.25979","article-title":"Marked factor V activity elevation in severe COVID-19 is associated with venous thromboembolism","volume":"95","author":"J A Stefely","year":"2020","journal-title":"Am J Hematol"},{"issue":"10","key":"ref93","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1160\/TH16-12-0904","article-title":"Coagulation factor XII regulates inflammatory responses in human lungs","volume":"117","author":"R Hess","year":"2017","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref94","first-page":"251","article-title":"Anticoagulant protein S in COVID-19: low activity, and associated with outcome","volume":"58","author":"L E Stoichitoiu","year":"2020","journal-title":"Rom J Intern Med"},{"issue":"21","key":"ref95","doi-asserted-by":"crossref","first-page":"15144","DOI":"10.1074\/jbc.274.21.15144","article-title":"Interaction between protein S and complement C4b-binding protein (C4BP). Affinity studies using chimeras containing c4bp \u03b2-chain short consensus repeats","volume":"274","author":"R H van de Poel","year":"1999","journal-title":"J Biol Chem"},{"issue":"10","key":"ref96","first-page":"001171","article-title":"Cerebral venous thrombosis and acute pulmonary embolism following varicella infection","volume":"6","author":"R Khan","year":"2019","journal-title":"Eur J Case Rep Intern Med"},{"issue":"03","key":"ref97","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/107999000312478","article-title":"Interaction between interleukin-6 and the natural anticoagulant system in acute stroke","volume":"20","author":"N Vila","year":"2000","journal-title":"J Interferon Cytokine Res"},{"issue":"02","key":"ref98","first-page":"327","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"P Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"issue":"06","key":"ref99","doi-asserted-by":"crossref","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","volume":"19","author":"D McGonagle","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"05","key":"ref100","first-page":"155","article-title":"Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients","volume":"45","author":"X Chen","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"04","key":"ref101","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.medmal.2020.04.002","article-title":"Interleukin-6 as a potential biomarker of COVID-19 progression","volume":"50","author":"Z S Ulhaq","year":"2020","journal-title":"Med Mal Infect"},{"issue":"16","key":"ref102","doi-asserted-by":"crossref","first-page":"15954","DOI":"10.18632\/aging.103869","article-title":"COVID-19: a probable role of the anticoagulant Protein S in managing COVID-19-associated coagulopathy","volume":"12","author":"S Chatterjee","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.thromres.2020.09.007","article-title":"Identification of the antithrombotic protein S as a potential target of the SARS-CoV-2 papain-like protease","volume":"196","author":"J A Ruzicka","year":"2020","journal-title":"Thromb Res"},{"issue":"04","key":"ref104","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1055\/s-0040-1716873","article-title":"Plasma antithrombin values are significantly decreased in coronavirus disease 2019 (COVID-19) patients with severe illness","volume":"47","author":"G Lippi","year":"2021","journal-title":"Semin Thromb Hemost"},{"issue":"07","key":"ref105","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/jth.14854","article-title":"The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome","volume":"18","author":"M Ranucci","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"07","key":"ref106","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1515\/cclm-2020-0188","article-title":"Prominent changes in blood coagulation of patients with SARS-CoV-2 infection","volume":"58","author":"H Han","year":"2020","journal-title":"Clin Chem Lab Med"},{"issue":"11","key":"ref107","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.numecd.2020.07.040","article-title":"Association between antithrombin and mortality in patients with COVID-19. A possible link with obesity","volume":"30","author":"C Gazzaruso","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"01","key":"ref108","first-page":"15","article-title":"Prognostic value of antithrombin levels in COVID-19 patients and impact of fresh frozen plasma treatment: a retrospective study","volume":"38","author":"\u0130 Anakl\u0131","year":"2021","journal-title":"Turk J Haematol"},{"issue":"09","key":"ref109","doi-asserted-by":"crossref","first-page":"e671","DOI":"10.1016\/S2352-3026(20)30217-9","article-title":"Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study","volume":"7","author":"D Liao","year":"2020","journal-title":"Lancet Haematol"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/S0140-6736(20)31041-2","article-title":"COVID-19-associated nephritis: early warning for disease severity and complications?","volume":"395","author":"O Gross","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"ref111","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1055\/s-0040-1714350","article-title":"Different hypercoagulable profiles in patients with COVID-19 admitted to the internal medicine ward and the intensive care unit","volume":"120","author":"A Boscolo","year":"2020","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref112","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1160\/TH15-08-0687","article-title":"Antithrombin: anti-inflammatory properties and clinical applications","volume":"115","author":"J H Levy","year":"2016","journal-title":"Thromb Haemost"},{"issue":"07","key":"ref113","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/ajh.25829","article-title":"Hematological findings and complications of COVID-19","volume":"95","author":"E Terpos","year":"2020","journal-title":"Am J Hematol"},{"issue":"03","key":"ref114","first-page":"125","article-title":"Heparin resistance","volume":"9","author":"J Bharadwaj","year":"2003","journal-title":"Lab Hematol"},{"issue":"05","key":"ref115","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1111\/bjh.16927","article-title":"Anticoagulation with argatroban in patients with acute antithrombin deficiency in severe COVID-19","volume":"190","author":"D J Arachchillage","year":"2020","journal-title":"Br J Haematol"},{"issue":"04","key":"ref116","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s11239-020-02300-7","article-title":"Thromboelastography findings in critically ill COVID-19 patients","volume":"51","author":"N Salem","year":"2021","journal-title":"J Thromb Thrombolysis"},{"issue":"02","key":"ref117","doi-asserted-by":"crossref","first-page":"193.e1","DOI":"10.1016\/j.jamcollsurg.2020.05.007","article-title":"Fibrinolysis shutdown correlation with thromboembolic events in severe COVID-19 infection","volume":"231","author":"F L Wright","year":"2020","journal-title":"J Am Coll Surg"},{"issue":"03","key":"ref118","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/SHK.0000000000001635","article-title":"Fibrinolysis shutdown and thrombosis in a COVID-19 ICU","volume":"55","author":"C Creel-Bulos","year":"2021","journal-title":"Shock"},{"issue":"02","key":"ref119","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11239-020-02226-0","article-title":"High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?","volume":"51","author":"C Iba\u00f1ez","year":"2021","journal-title":"J Thromb Thrombolysis"},{"issue":"02","key":"ref120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.aucc.2020.07.003","article-title":"Evaluation of coagulation status using viscoelastic testing in intensive care patients with coronavirus disease 2019 (COVID-19): an observational point prevalence cohort study","volume":"34","author":"L W Collett","year":"2021","journal-title":"Aust Crit Care"},{"issue":"09","key":"ref121","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1055\/s-0040-1713637","article-title":"Fibrinolysis resistance: a potential mechanism underlying COVID-19 coagulopathy","volume":"120","author":"E Weiss","year":"2020","journal-title":"Thromb Haemost"},{"issue":"47","key":"ref122","doi-asserted-by":"crossref","first-page":"e23365","DOI":"10.1097\/MD.0000000000023365","article-title":"The haemostatic profile in critically ill COVID-19 patients receiving therapeutic anticoagulant therapy: an observational study","volume":"99","author":"A E Tsantes","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"ref123","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1111\/jth.15043","article-title":"In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation","volume":"18","author":"A Blasi","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref124","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3390\/ijms22031283","article-title":"The central role of fibrinolytic response in COVID-19\u2014a hematologist's perspective","volume":"22","author":"H C Kwaan","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"03","key":"ref125","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1055\/s-0038-1656009","article-title":"Haemostatic properties of human pulmonary and cerebral microvascular endothelial cells","volume":"77","author":"G E Grau","year":"1997","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref126","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1592\/phco.27.6.860","article-title":"Emerging role of anticoagulants and fibrinolytics in the treatment of acute respiratory distress syndrome","volume":"27","author":"R MacLaren","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"07","key":"ref127","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/jth.14872","article-title":"Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19","volume":"18","author":"C S Whyte","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"12","key":"ref128","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1164\/rccm.200208-905OC","article-title":"Thrombin-activatable fibrinolysis inhibitor and protein C inhibitor in interstitial lung disease","volume":"167","author":"H Fujimoto","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"03","key":"ref129","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00264-005-0067-6","article-title":"Changes in coagulation and fibrinolysis of post-SARS osteonecrosis in a Chinese population","volume":"30","author":"W Sun","year":"2006","journal-title":"Int Orthop"},{"key":"ref130","first-page":"181","volume-title":"Thrombohemostatic disorder in new viral emerging diseases","author":"V Wiwanitkit","year":"2006"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.thromres.2020.10.025","article-title":"Prothrombotic disturbances of hemostasis of patients with severe COVID-19: a prospective longitudinal observational study","volume":"197","author":"M Hardy","year":"2021","journal-title":"Thromb Res"},{"issue":"06","key":"ref132","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/CIRCULATIONAHA.120.048925","article-title":"Systemic inflammatory response syndrome is a major contributor to COVID-19-associated coagulopathy: insights from a prospective, single-center cohort study","volume":"142","author":"P Masi","year":"2020","journal-title":"Circulation"},{"issue":"02","key":"ref133","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/10245330400026170","article-title":"Thrombocytopenia in patients with severe acute respiratory syndrome (review)","volume":"10","author":"M Yang","year":"2005","journal-title":"Hematology"},{"key":"ref134","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(03)13412-5","article-title":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study","volume":"361","author":"J SM Peiris","year":"2003","journal-title":"Lancet"},{"issue":"20","key":"ref135","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJMoa030685","article-title":"A major outbreak of severe acute respiratory syndrome in Hong Kong","volume":"348","author":"N Lee","year":"2003","journal-title":"N Engl J Med"},{"issue":"04","key":"ref136","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1086\/380973","article-title":"Prognostic factors for severe acute respiratory syndrome: a clinical analysis of 165 cases","volume":"38","author":"Z Zou","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"20","key":"ref137","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1056\/NEJMoa030666","article-title":"A cluster of cases of severe acute respiratory syndrome in Hong Kong","volume":"348","author":"K W Tsang","year":"2003","journal-title":"N Engl J Med"},{"issue":"02","key":"ref138","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1378\/chest.126.2.509","article-title":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever","volume":"126","author":"C-L Liu","year":"2004","journal-title":"Chest"},{"issue":"05","key":"ref139","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3201\/eid1005.030640","article-title":"Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients","volume":"10","author":"J-T Wang","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"06","key":"ref140","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1080\/00313020310001619118","article-title":"A clinicopathological study of three cases of severe acute respiratory syndrome (SARS)","volume":"35","author":"Z W Lang","year":"2003","journal-title":"Pathology"},{"issue":"01","key":"ref141","doi-asserted-by":"crossref","first-page":"25359","DOI":"10.1038\/srep25359","article-title":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity","volume":"6","author":"C-K Min","year":"2016","journal-title":"Sci Rep"},{"issue":"05","key":"ref142","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jinf.2016.08.005","article-title":"Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients","volume":"73","author":"J-H Ko","year":"2016","journal-title":"J Infect"},{"issue":"26","key":"ref143","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1303729","article-title":"Family cluster of Middle East respiratory syndrome coronavirus infections","volume":"368","author":"Z A Memish","year":"2013","journal-title":"N Engl J Med"},{"issue":"05","key":"ref144","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1306742","article-title":"Hospital outbreak of Middle East respiratory syndrome coronavirus","volume":"369","author":"A Assiri","year":"2013","journal-title":"N Engl J Med"},{"issue":"03","key":"ref145","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ijlh.12620","article-title":"Hematologic, hepatic, and renal function changes in hospitalized patients with Middle East respiratory syndrome coronavirus","volume":"39","author":"J A Al-Tawfiq","year":"2017","journal-title":"Int J Lab Hematol"},{"issue":"04","key":"ref146","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/09537104.2020.1754383","article-title":"Association between platelet parameters and mortality in coronavirus disease 2019: retrospective cohort study","volume":"31","author":"Y Liu","year":"2020","journal-title":"Platelets"},{"key":"ref147","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.thromres.2020.06.008","article-title":"Mechanisms involved in the development of thrombocytopenia in patients with COVID-19","volume":"193","author":"Y Zhang","year":"2020","journal-title":"Thromb Res"},{"issue":"06","key":"ref148","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/jth.14848","article-title":"Thrombocytopenia and its association with mortality in patients with COVID-19","volume":"18","author":"X Yang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"ref149","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","article-title":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis","volume":"506","author":"G Lippi","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"01","key":"ref150","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1111\/bjh.16817","article-title":"The association between severe COVID-19 and low platelet count: evidence from 31 observational studies involving 7613 participants","volume":"190","author":"S Q Jiang","year":"2020","journal-title":"Br J Haematol"},{"issue":"05","key":"ref151","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19","volume":"18","author":"J Thachil","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"08","key":"ref152","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/jth.14879","article-title":"What do monitoring platelet counts in COVID-19 teach us?","volume":"18","author":"J Thachil","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref153","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/jth.14788","article-title":"Large and small platelets-(When) do they differ?","volume":"18","author":"S Handtke","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref154","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/jth.14832","article-title":"Exploring possible mechanisms for COVID-19 induced thrombocytopenia: unanswered questions","volume":"18","author":"A Amgalan","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"11","key":"ref155","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in patients with COVID-19","volume":"136","author":"B K Manne","year":"2020","journal-title":"Blood"},{"key":"ref156","doi-asserted-by":"crossref","first-page":"100434","DOI":"10.1016\/j.eclinm.2020.100434","article-title":"Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: a case series","volume":"24","author":"A V Rapkiewicz","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"09","key":"ref157","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/CCM.0000000000004458","article-title":"Coagulopathy of coronavirus disease 2019","volume":"48","author":"T Iba","year":"2020","journal-title":"Crit Care Med"},{"issue":"05","key":"ref158","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/09537104.2020.1762852","article-title":"Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19)","volume":"31","author":"F Salamanna","year":"2020","journal-title":"Platelets"},{"issue":"01","key":"ref159","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13045-020-00954-7","article-title":"SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19","volume":"13","author":"S Zhang","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"01","key":"ref160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s10020-020-00230-x","article-title":"IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19","volume":"26","author":"Y Chen","year":"2020","journal-title":"Mol Med"},{"issue":"07","key":"ref161","doi-asserted-by":"crossref","first-page":"448","DOI":"10.14740\/jocmr4240","article-title":"Use of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in COVID-19","volume":"12","author":"A S Chan","year":"2020","journal-title":"J Clin Med Res"},{"issue":"S 01","key":"ref162","first-page":"531","article-title":"Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in COVID-19 patients and control group and relationship with disease prognosis","volume":"11","author":"M Eslamijouybari","year":"2020","journal-title":"Caspian J Intern Med"},{"issue":"01","key":"ref163","doi-asserted-by":"crossref","first-page":"e23607","DOI":"10.1002\/jcla.23607","article-title":"Mean platelet volume\/platelet count ratio predicts severe pneumonia of COVID-19","volume":"35","author":"Q Zhong","year":"2021","journal-title":"J Clin Lab Anal"},{"issue":"01","key":"ref164","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1186\/s13054-020-03339-x","article-title":"Dynamic trajectory of platelet-related indicators and survival of severe COVID-19 patients","volume":"24","author":"J He","year":"2020","journal-title":"Crit Care"},{"issue":"03","key":"ref165","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jacbts.2020.12.009","article-title":"Platelet and endothelial activation as potential mechanisms behind the thrombotic complications of COVID-19 patients","volume":"6","author":"P Canzano","year":"2021","journal-title":"JACC Basic Transl Sci"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1736166.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T01:11:07Z","timestamp":1643764267000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1736166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,25]]},"references-count":164,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2022,2,1]]},"published-print":{"date-parts":[[2022,2]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1736166","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,25]]}}}